<DOC>
	<DOCNO>NCT02247817</DOCNO>
	<brief_summary>Cardiac resynchronization therapy become one cornerstones treatment heart failure . However , large proportion patient still fail type therapy . This may due suboptimal position leave ventricular pace lead , may cause unfavorable cardiac venous anatomy . Implantation pace lead use video assist thoracic surgery flexible evades venous system altogether , result much favorable position pace lead , good treatment result e consequence .</brief_summary>
	<brief_title>A Combined Transvenous Epicardial Lead Placement Procedure Implantation Cardiac Resynchronization Devices : Feasibility Study .</brief_title>
	<detailed_description />
	<mesh_term>Heart Failure</mesh_term>
	<criteria>Inclusion criterion NYHA class IIIII . Left ventricular ejection fraction ≤ 35 % . QRSduration ≥ 120 m ( NYHA III ) ≥ 130 m ( NYHA II ) leave bundle branch block morphology . No sidebranch coronary sinus near posterolateral wall leave ventricle and/or presence Thebesian valve reduces coronary sinus diameter 50 % ( correspond decrease cross sectional area 75 % ) . On optimal medical therapy heart failure , include betablockers , ACEinhibitors , AT2antagonists aldosteron antagonist . Age ≥ 18 year . Signed informed consent . Exclusion criteria A potential subject meet follow criterion exclude participation study : Coronary ischemia recent myocardial infarction ( &lt; 6 month ) . Allready CRTdevice implant . Venous thrombosis without option reach right heart . Presence condition HF life expectancy &lt; 1 year . History intrathoracic surgery . Presence suspect presence noncompliant leave lung . Participation another intervention trial . Unable understand Dutch language . Pregnant woman .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2014</verification_date>
</DOC>